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Abstract: A novel method for the preparation of the spirocyclic
Δβ,γ-butenolides is presented. The developed strategy is based on a
trienamine-mediated [4+2]-cycloaddition between (E)-3-al-
kylidene-5-arylfuran-2(3H)-ones and 2,4-dienals. Target products
containing three contiguous centres including one quaternary are ef-
ficiently formed in a highly enantiomerically enriched form in the
presence of the silyl-protected diphenylprolinol aminocatalyst.
Key words: asymmetric synthesis, aminocatalysis, trienamines,
Δβ,γ-butenolides, quaternary stereogenic center
Asymmetric aminocatalysis1 where chiral primary or sec-
ondary amines are employed as catalysts of various chem-
ical transformations constitute an interesting field of
research that has been developing intensively since its re-
discovery in 2000.1a,b The application of enamines and
iminium-ions as reactive catalytic intermediates has been
widely studied establishing these two activation modes
among the most reliable tools in the asymmetric cataly-
sis.1c–e Recently, the aminocatalytic principles have been
extended allowing for the introduction of new stereogenic
centres up to seven bonds away from the chirality of the
catalyst.2 Such a remote functionalization strategies pro-
ceeding via the intermediacy of dienamines or trienam-
ines as reactive intermediates are receiving an increasing
attention from the chemical community and reveal a po-
tential of aminocatalysts to control not only stereoselec-
tivity but also site-selectivity of promoted reactions.
Δ-Butenolides constitute a group of unsaturated γ-lac-
tones that is widely distributed in nature (Scheme 1, top).3
Their biological activity is well recognized and many
members of that family has found application in the life-
science industry. Furthermore, Δ-butenolides are useful
intermediates in the target-oriented organic synthesis.4
Although the synthetic routes for the preparation of Δα,β-
butenolides are well established,5 the general methods for
the synthesis of their Δβ,γ-counterparts are much less com-
mon.6
Taking into account the importance and interesting bio-
logical activity of the Δβ,γ-butenolide framework and the
limited availability of methods for their preparation, in
particular in an enantioselective fashion, we undertook
studies on the development of a facile and stereoselective
approach to this group of compounds. We envisioned that
a direct and facile approach to Δ-butenolides 4 might rely
on a trienamine-mediated reaction between 2,4-dienals 1
and (E)-3-alkylidene-5-substituted furan-2(3H)-ones 2
(Scheme 1, bottom). The reaction was expected to operate
via the C-4-C-5-s-cis-configured trienamine intermediate.
Furthermore, due to the bulkiness of the substituent pres-
ent at the C-2 atom of the catalyst a formal [4+2]-cycload-
dition should proceed in a highly stereoselective manner
from the side opposite to the steric bulk of the aminocata-
lyst 3. Herein, we report our results on a novel and enan-
tioselective approach to spirocyclic Δβ,γ-butenolides
based on a trienamine activation strategy.
Scheme 1  The importance of a Δ-butenolide structural motif and
an enantioselective strategy for the preparation of spirocyclic
Δβ,γ-butenolides
We initiated our studies with the goal of finding the opti-
mal reaction conditions for the devised synthetic strategy
(Table 1). The commercially available 2,4-hexadienal
(1a) and (E)-3-benzylidene-5-phenylfuran-2(3H)-one
(2a) were chosen as model substrates. Among solvents
tested (Table 1, entries 1–7) chlorinated solvents (Table 1,
entries 1–3) gave the best results with dichloromethane
being the most optimal (Table 1, entry 2). Increasing the
reaction temperature resulted in no improvement of the
conversion with the diastereoselectivity of the reaction
being decreased (Table 1, entry 8). Among aminocatalysts
3a–d tested, the TES-protected diphenylprolinol 3b
proved the best in terms of reactivity ensuring good level
of diastereoselectivity and excellent enantioselectivity at
the same time. Finally, employing three-fold excess of 1a
enabled us to achieve full conversion within 24 hours.
Having optimized the reaction conditions, the studies on
the scope of the developed methodology were undertaken.
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Initially the usefulness of different olefinic butenolides 2
in the developed cycloaddition was investigated. For the
isolation purposes and to be able to directly determine en-
antioselectivity of the trienamine-mediated reaction,
crude [4+2]-cycloadducts 4 were directly subjected to the
Ramirez olefination affording dibromo derivatives 5 as
the final products. Importantly, in all of the cases the ma-
jor diastereoisomer of the product 5 could be easily sepa-
rated by flash chromatography. In the first part of the
scope studies the possibility to introduce various aromatic
substituents on the alkylidene moiety of dienophiles 2 was
investigated (Table 2). It was found that the reaction pro-
ceeded efficiently for a wide variety of butenolides 2. In
terms of stereoselectivity both electron-withdrawing (Ta-
ble 2, entries 2–7) and electron-donating substituents (Ta-
ble 2, entries 8 and 9) were well tolerated with lower
yields being observed for the latter. Importantly, excellent
enantioselectivities were obtained for most of the cases.
Furthermore, the position of the substituent had no major
influence on the reaction outcome (Table 2, compare en-
tries 2–5).
In the course of the further studies the possibility to intro-
duce various substituents at the C-5 position of the
butenolide framework was investigated (Scheme 2). Im-
portantly, it was found that the reaction was unbiased to-
wards the electronic properties of the aromatic ring in this
position and both electron-poor and electron-rich aromat-
ic rings could be present as demonstrated in the synthesis
of 5j and 5k.
In the final part of the studies various 2,4-dienals 1 were
evaluated (Scheme 3). The possibility to introduce substit-
Table 1  Enantioselective Synthesis of Spirocyclic Δβ,γ-Butenolides: 
Optimization Studiesa
Entry Solvent Cat. Temp Conv. 
[yield (%)]b
drc ee (%)d
1 CHCl3 3a r.t. 54 2:1 nd
2 CH2Cl2 3a r.t. 72 (45) 2:1 98
3 CCl4 3a r.t. 29 1:1 nd
4 MeCN 3a r.t. 29 1:1 nd
5 toluene 3a r.t. 21 1:1 nd
6 Et2O 3a r.t. 22 1:1 nd
7 i-PrOH 3a r.t. 18 1:1 nd
8 CH2Cl2 3a 40 °C 70 1:1 nd
9 CH2Cl2 3b r.t. 88 (52) 3.5:1 99
10 CH2Cl2 3c r.t. 78 4:1 97
11 CH2Cl2 3d r.t. 10 >20:1 nd
12e CH2Cl2 3b r.t. >95 (65) 3.5:1 98
a Reactions were performed on a 0.1 mmol scale.
b Conversion as determined by 1H NMR of a crude reaction mixture. 
Given in parentheses are the isolated yields after the Ramirez olefina-
tion of the initial cycloadduct 4a.
c Determined by 1H NMR of a crude reaction mixture.
d Enantiomeric excess of the major diastereoisomer as determined by 
a chiral stationary phase HPLC on a Ramirez olefination product 5a.
e Three equivalents of 1a were used.
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Table 2  Enantioselective Synthesis of Spirocyclic Δβ,γ-Butenolides: 
(E)-3-Alkylidene-5-phenylfuran-2(3H)-one Scopea
Entry R Yield (%)b drc ee (%)d
1 Ph (5a) 65 3.5:1 98
2 2-FC6H4 (5b) 52 2:1 98
3 3-FC6H4 (5c) 54 1.5:1 89
4 3-ClC6H4 (5d) 62 1.5:1 92
5 4-BrC6H4 (5e) 28 1:1 >99
6 4-F3CC6H4 (5f) 44 2:1 >99
7 4-NCC6H4 (5g) 26 1:1 98
8 4-MeC6H4 (5h) 48 2:1 98
9 4-MeOC6H4 (5i) 33 3:1 98
a Reactions were performed on 0.2 mmol scale.7
b Isolated yields over two steps.
c Determined by 1H NMR of the crude reaction mixture.
d Enantiomeric excess of the major diastereoisomer as determined by 
a chiral stationary phase HPLC.
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uents at the 4- and 5-position of 2,4-dienals 1 was investi-
gated. In both cases similar good results were obtained.
Absolute configuration of the major diastereoisomer of
the final products was unambiguously assigned by a sin-
gle crystal X-ray analysis of the compound 5d as
5S,6S,10R (Scheme 4, top).8 The absolute configuration
of other major products 5a–c,e–m was assigned by analo-
gy. This configurational assignment allowed us to propose
a plausible reaction mechanism of the reaction accounting
for the observed stereochemistry (Scheme 4, bottom). Ini-
tial condensation of a dienal 1 with the aminocatalyst 3b
followed by a deprotonation from the ε-position and isom-
erisation affords a trienamine intermediate 7 which reacts
in a s-cis conformation. The endo approach of the dieno-
phile 2 is favoured. Taking into account previous studies
on the trienamine-mediated reactions9 a stepwise mecha-
nism for the cycloaddition step is postulated. Initial 1,4-
addition from the ε-position of the trienamine intermedi-
ate 7 yields adduct 8 bearing an aromatic furan moiety.
Subsequent intramolecular 1,4-addition involving the
iminium-ion-activated Michael acceptor furnishes the
cyclohexene framework in 9. The catalytic cycle is ac-
complished via an enamine protonation and subsequent
hydrolytic cleavage of the catalyst to afford the target spi-
rocyclic Δβ,γ-butenolide 4.
Scheme 2  Enantioselective synthesis of spirocyclic Δβ,γ-butenolides 5: (E)-5-aryl-3-benzylidenefuran-2(3H)-one scope
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Scheme 3  Enantioselective synthesis of spirocyclic Δβ,γ-butenolides 5: scope of 2,4-dienals 1
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Scheme 4  Enantioselective synthesis of Δβ,γ-butenolides 4: reaction
mechanism and configurational assignments of the major diastereo-
isomer
The relative configuration of the minor diastereoisomer
was elucidated by the means of the 1H NMR spectroscopy
(Scheme 5). It was found that the main difference in the
spectra of the two diastereoisomers was the chemical shift
of the proton in the C6 position and in the exocyclic meth-
ylene moiety (1′ position). While in the major diastereo-
isomers the chemical shift of the H6 proton was in the
range δ = 2.46–2.50, it shifted quite dramatically in the
minor diasteroisomers’ spectra (δ = 2.99–3.15 ppm). A
similar but opposite trend was observed for the H1′ pro-
tons (a shift from δ = 2.56–2.64 ppm and δ = 2.32–2.37
ppm for the major diastereoisomers to δ = 1.96–2.14 ppm
for the minor diastereoisomers). Such a pronounced
change in the chemical shifts of the protons in the direct
neighbourhood of the C6 stereogenic centre can be ex-
plained by the endo/exo approach of the dienophile. The
most stable half-chair conformations of both diastereoiso-
mers are depicted in Scheme 5. The observed effect can be
attributed to the shielding effect of the π-electrons of the
butenolide moiety exerted on the substituent occupying
the C6 pseudoequatorial position on the cyclohexene
framework. Therefore, in the major endo diastereoisomer
H6 proton is strongly shielded by the butenolide ring
causing its upfield shift and downfield shift of the desh-
ielded exocyclic CH2 group at the same time. Notably,
this is in accordance with the outcome of the single crystal
X-ray analysis (see Scheme 4). On the other hand, in the
minor/exo product exocyclic CH2 group occupies a pseu-
doequatorial position. Therefore, due to the mentioned
shielding effect its signal in the 1H NMR spectra appears
in the upfield. Consequently, the H6 proton chemical shift
is shifted downfield.
Scheme 5  Assignment of the configuration of the minor diastereo-
isomer and further mechanistic consideration
In conclusion, we have developed a novel approach to spi-
rocyclic butenolide-containing cyclohexene derivatives 5
with three contiguous stereogenic centres including one
quaternary.10 The reaction was found to proceed for a
wide variety of 2,4-dienals and olefinic butenolides offer-
ing a general approach to this class of compounds. For the
isolation purposes the products were directly subjected to
the Ramirez olefination and the target products were iso-
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lated as geminal-dibromo derivatives. It is noteworthy
that the developed synthetic strategy is highly enantiose-
lective and benefits from operational simplicity. Further-
more, it opens access to a novel class of spirocyclic
butenolides with intriguing biological properties.
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